Neuropsychiatric Disease and Treatment Journal Citation Rate 2026

ISSN 1176-6328 eISSN 1178-2021 Dove Medical Press NZ

Q2 Quartile Open Access Established Impact

About Neuropsychiatric Disease and Treatment
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Neuropsychiatric Disease and Treatment (NDT) is a peer-reviewed academic journal covering Attention Deficit Hyperactivity Disorder and Bipolar Disorder and Treatment, published by Dove Medical Press in NZ, catalogued under ISSN 1176-6328 (e-ISSN 1178-2021). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.37 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2836 USD.

Neuropsychiatric Disease and Treatment Citation Rate 2026 — In Context

Neuropsychiatric Disease and Treatment has a 2025 2-Year Citation Rate (OpenAlex) of 2.37, placing it in the Q2 quartile within the Attention Deficit Hyperactivity Disorder research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Neuropsychiatric Disease and Treatment makes all articles freely available to readers for an Article Processing Charge of approximately $2836 USD.

Researchers looking to publish in Neuropsychiatric Disease and Treatment should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Neuropsychiatric Disease and Treatment against similar journals in the field, use our journal comparison tool.

Submission Tips for Neuropsychiatric Disease and Treatment
  • Budget $2836 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Attention Deficit Hyperactivity Disorder, Bipolar Disorder and Treatment, Schizophrenia research and treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Neuropsychiatric Disease and … Compares
Citation Rate vs Field Avg
-8%
Field avg: 2.58
APC vs Field Avg
-8%
Field avg: $3068

Compared against 19 journals in the same research areas.

ISSN (Print) 1176-6328
ISSN (Online) 1178-2021
Publisher Dove Medical Press
Country New Zealand
APC / Cost $2836 USD
In-depth profile & metrics

Neuropsychiatric Disease and Treatment is published by Dove Medical Press and based in New Zealand. It publishes open access with an article-processing charge of USD 2836.

In our subject taxonomy, Neuropsychiatric Disease and Treatment is classified under Attention Deficit Hyperactivity Disorder, Bipolar Disorder and Treatment, Schizophrenia research and treatment and Treatment of Major Depression.

Neuropsychiatric Disease and Treatment is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.366.

Research Areas
Links
Frequently Asked Questions about Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.366 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Neuropsychiatric Disease and Treatment is an open access journal.

The Article Processing Charge (APC) for Neuropsychiatric Disease and Treatment is $2836 USD.

Neuropsychiatric Disease and Treatment is published by Dove Medical Press.

Neuropsychiatric Disease and Treatment shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Neuropsychiatric Disease and Treatment is 1176-6328. Its electronic ISSN (eISSN) is 1178-2021.

Neuropsychiatric Disease and Treatment sits in the Q2 quartile based on its latest impact factor of 2.37, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
2.366
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.366 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S124245730

Get weekly updates for Attention Deficit Hyperactivity Disorder journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google